Drug Companies Update May 2009
Mergers, acquisitions & Joint Ventures
- Avigenics has changed its name to Synageva BioPharma.
- Endo Pharmaceuticals has acquired Indevus.
- Innodia has been acquired by Bellus Health.
- Magen Biosciences has been acquired by PPD.
- The Medicines Company has bought Targanta Therapeutics, which will remain as a wholly-owned subsidiary.
- Neosil has been acquired by Peplin.
- Neuropharma has changed its name and will henceforth be known as Noscira.
- Ovation Pharmaceuticals has become a fully-integrated subsidiary of Lundbeck.
- PDL BioPharma has spun-off all biotech operations into Facet.
- Industry heavyweight Roche has completed its acquisition of Genentech.
- StemCells Inc has acquired Stem Cell Sciences.
- Virochem has been acquired by Vertex.
New Companies
- ACT Biotech was spun off from Bayer Healthcare to develop and commercialise targeted oral anticancers.
- Adaptimmune is a biotech outfit focusing on the development of T-cell therapies for cancer and infectious disease.
- Alnara Pharmaceuticals is developing protein therapeutics for the treatment of metabolic disease.
- Binex is a S Korean biotech company.
- BiondVax Pharmaceuticals is an Israeli biotech company developing universal multiseason and multistrain influenza vaccines.
- BruCells was established to develop dendritic cell-based therapeutics vaccines based on research carried out by the Universite de Bruxelles and Vrije de Universiteit Brussel.
- CHA Bio & Diostech is focused on stem cell research and regenerative medicine.
- China Medical System is a fully-integrated pharmaceutical group focused on all stages of development and marketing.
- Chongqun Jiachen is developing a therapeutic hepatitis-B vaccine.
- Cyrenaic is developing an antipsychotic compound in-licensed fom Mitsubishi.
- Cytomedix is a biotech concerned with advanced tissue regeneration technologies to manage wound healing.
- DaVinci Biosciences is developing small molecules and cell therapies for the treatment of neurodegenartive disorders.
- Eiger BioPharmaceuticals develops NCEs, reprofiled drugs and drug combinations as antivirals.
- Evoke Pharma is a specialty pharmaceutical company focused on treatments for gastrointestinal diseases.
- Eyetech was spun off from OSI Pharmaceuticals and holds assests related to pegatinib octasodium (Macugen).
- Immunotech Laboratories is developing proprietary proteins for the treatment of infectious diseases, including HIV.
- Lumavita is a specialty biopharmaceutical company dedicated to developing novel anti-infectives for women's health.
- Novira Therapeutics is a life sciences company focused on small molecule antivirals based on virus-host interactions.
- NovoLytics is a biotech company developing bacteriophages for infectious and parasitic disease.
- Pearl Therapeutics develops compounds for the treatment of respiratory disease using a particle technology licensed from Nektar Therapeutics.
- Provenance Biopharmaceuticals is a biotech company developing novel immunotherapeutics to treat cancer and other serious diseases.
- Roxall Medizin is involved in the development of therapeutics and diagnostics immunology and allergology.
- Samtheo Bioharma is focused on the delivery of personalised medicine through targeted therapeutics.
- Strides Arcolab is concerned with the development and manufacturing of pharmaceutical dosage forms.
- TauTaTis is developing compounds that interfere with aberrant processes in degenerating nerve cells.
- Ugichem is an Austrian biotech company developing cell membrane crossing oligomers as a new generation of antisense drugs.
- VivaCell Biotechnology is focused on the development of products derived from plants and marine organisms.
